Cargando…
Can antipsychotic use protect from COVID-19?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321781/ https://www.ncbi.nlm.nih.gov/pubmed/34352504 http://dx.doi.org/10.1016/j.schres.2021.07.035 |
| _version_ | 1783730925716111360 |
|---|---|
| author | Dratcu, Luiz Boland, Xavier |
| author_facet | Dratcu, Luiz Boland, Xavier |
| author_sort | Dratcu, Luiz |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8321781 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Published by Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83217812021-07-30 Can antipsychotic use protect from COVID-19? Dratcu, Luiz Boland, Xavier Schizophr Res Letter to the Editor Published by Elsevier B.V. 2021-10 2021-07-30 /pmc/articles/PMC8321781/ /pubmed/34352504 http://dx.doi.org/10.1016/j.schres.2021.07.035 Text en Crown Copyright © 2021 Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Dratcu, Luiz Boland, Xavier Can antipsychotic use protect from COVID-19? |
| title | Can antipsychotic use protect from COVID-19? |
| title_full | Can antipsychotic use protect from COVID-19? |
| title_fullStr | Can antipsychotic use protect from COVID-19? |
| title_full_unstemmed | Can antipsychotic use protect from COVID-19? |
| title_short | Can antipsychotic use protect from COVID-19? |
| title_sort | can antipsychotic use protect from covid-19? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321781/ https://www.ncbi.nlm.nih.gov/pubmed/34352504 http://dx.doi.org/10.1016/j.schres.2021.07.035 |
| work_keys_str_mv | AT dratculuiz canantipsychoticuseprotectfromcovid19 AT bolandxavier canantipsychoticuseprotectfromcovid19 |